Brief: Novabay Pharmaceuticals CEO Issues Letter To Stockholders

Stablecoin Development

25/04/2022 11:56

April 25 (Reuters) - NovaBay Pharmaceuticals Inc  NBY.A :
    * NOVABAY PHARMACEUTICALS CEO ISSUES LETTER TO STOCKHOLDERS
    * NOVABAY PHARMACEUTICALS INC - EXPECT MAJORITY OF OUR GROWTH IN 2022 WILL
COME IN
SECOND HALF OF YEAR
    * NOVABAY PHARMACEUTICALS INC - TO DATE CO HAS EXPERIENCED ONLY MINOR SUPPLY
CHAIN
DISRUPTIONS, LIMITING INFLATIONARY IMPACT ON BUSINESS
    * NOVABAY PHARMACEUTICALS INC -  TO MITIGATE ANY NEGATIVE INFLATIONARY
IMPACT,
WILL LIKELY NEED TO MODESTLY INCREASE PRODUCT PRICES TO SUPPORT MARGINS

Source text for Eikon:  ID:nBw5g4DHLa 
Further company coverage:  NBY.A 

 ((Reuters.Briefs@thomsonreuters.com;))